Iovance Biotherapeutics News

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G

Apr 17 19:10 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH

Apr 17 19:10 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR

Apr 17 19:10 ET

Iovance Biotherapeutics | 8-K: Current report

Apr 3 17:19 ET

Iovance Biotherapeutics | 8-K: Current report

Mar 29 17:04 ET

Iovance Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Quogue Capital LLC(11.6%),Wayne P. Rothbaum(11.6%)

Mar 19 17:23 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G

Mar 6 18:49 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH

Mar 6 18:48 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR

Mar 6 18:48 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Maynard Ryan D

Mar 5 18:00 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vogt Frederick G

Mar 5 18:00 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rothbaum Wayne P.

Mar 5 17:59 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director YARNO WENDY L

Mar 5 17:59 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director WEISER MICHAEL

Mar 5 17:59 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director MCPEAK MERRILL A

Mar 5 17:59 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dukes Iain D.

Mar 5 17:59 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Countouriotis Athena

Mar 5 17:55 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bellemin Jean-Marc

Mar 5 17:55 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BILINSKY IGOR

Mar 5 17:54 ET

Iovance Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAF FINCKENSTEIN FRIEDRICH

Mar 5 17:54 ET